Browse/search for people

Publication - Professor Polly Bingley

    Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies

    Citation

    Schlosser, M, Mueller, P, Törn, C, Bonifacio, E, Bingley, P & Participating, L, 2010, ‘Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies’. Diabetologia, vol 53(12)., pp. 2611 - 2620

    Abstract

    AIMS/HYPOTHESIS: Insulin autoantibodies (IAA) are important in type 1 diabetes risk assessment. However, their determination varies more between laboratories than other diabetes autoantibodies. The Diabetes Antibody Standardization Program (DASP) aims to improve and standardise measurement of autoantibodies associated with type 1 diabetes. We report the results of measurement of IAA from DASP workshops in 2002, 2003 and 2005.

    METHODS: Up to 32 laboratories in 14 countries participated in each workshop. Aliquots of coded sera from 50 patients with newly diagnosed type 1 diabetes and 100 blood donor controls were circulated to participating laboratories. Reported results were analysed using receiver operator characteristic (ROC) curves. We compared concordance of antibody levels by ranking, IAA and insulin antibody (IA) indices and units derived from an IA standard curve.

    RESULTS: In all three workshops IAA assay performance had improved compared with DASP 2000. The median area under the ROC curve was 0.73 in DASP 2002, 0.78 in 2003 and 0.80 in 2005 (p = 0.0012), and median laboratory-assigned sensitivity was 26% in 2002, 36% in 2003 and 45% in 2005 (p 

    Full details in the University publications repository